JP2008517897A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008517897A5 JP2008517897A5 JP2007537410A JP2007537410A JP2008517897A5 JP 2008517897 A5 JP2008517897 A5 JP 2008517897A5 JP 2007537410 A JP2007537410 A JP 2007537410A JP 2007537410 A JP2007537410 A JP 2007537410A JP 2008517897 A5 JP2008517897 A5 JP 2008517897A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- aryl
- defined above
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 28
- 125000005842 heteroatom Chemical group 0.000 claims description 22
- 125000003118 aryl group Chemical group 0.000 claims description 20
- 125000001072 heteroaryl group Chemical group 0.000 claims description 17
- 125000004429 atom Chemical group 0.000 claims description 16
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 12
- 125000005843 halogen group Chemical group 0.000 claims description 10
- 125000001475 halogen functional group Chemical group 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 8
- 125000000623 heterocyclic group Chemical group 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 150000004677 hydrates Chemical class 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- -1 polyfluoroalkyl Chemical group 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000012453 solvate Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 101000693265 Homo sapiens Sphingosine 1-phosphate receptor 1 Proteins 0.000 claims 1
- 102000011011 Sphingosine 1-phosphate receptors Human genes 0.000 claims 1
- 239000000018 receptor agonist Substances 0.000 claims 1
- 229940044601 receptor agonist Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04292517A EP1650186B1 (en) | 2004-10-22 | 2004-10-22 | Novel dicarboxylic acid derivatives |
| PCT/IB2005/003113 WO2006043149A2 (en) | 2004-10-22 | 2005-10-18 | Novel dicarboxylic acid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008517897A JP2008517897A (ja) | 2008-05-29 |
| JP2008517897A5 true JP2008517897A5 (enExample) | 2012-05-31 |
Family
ID=34931473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007537410A Pending JP2008517897A (ja) | 2004-10-22 | 2005-10-18 | 新規なジカルボン酸誘導体 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20090264469A1 (enExample) |
| EP (1) | EP1650186B1 (enExample) |
| JP (1) | JP2008517897A (enExample) |
| KR (1) | KR20070097418A (enExample) |
| CN (1) | CN101107218A (enExample) |
| AP (1) | AP2007004001A0 (enExample) |
| AT (1) | ATE397582T1 (enExample) |
| AU (1) | AU2005297138A1 (enExample) |
| BR (1) | BRPI0516988A (enExample) |
| CA (1) | CA2584610A1 (enExample) |
| CY (1) | CY1108321T1 (enExample) |
| DE (1) | DE602004014277D1 (enExample) |
| DK (1) | DK1650186T3 (enExample) |
| EA (1) | EA200700931A1 (enExample) |
| ES (1) | ES2308127T3 (enExample) |
| HR (1) | HRP20080431T3 (enExample) |
| IL (1) | IL182678A0 (enExample) |
| MX (1) | MX2007004847A (enExample) |
| PL (1) | PL1650186T3 (enExample) |
| PT (1) | PT1650186E (enExample) |
| SI (1) | SI1650186T1 (enExample) |
| WO (1) | WO2006043149A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2014653A1 (en) * | 2007-06-15 | 2009-01-14 | Bioprojet | Novel dicarboxylic acid derivatives as S1P1 receptor agonists |
| ATE505454T1 (de) * | 2007-09-20 | 2011-04-15 | Amgen Inc | 1-(4-(4-benzylbenzamid)-benzyl)-azetidin-3- carboxylsäurederivate und entsprechende verbindungen als s1p-rezeptor-modulatoren zur behandlung von immunerkrankungen |
| PL2291080T3 (pl) | 2008-05-14 | 2015-12-31 | Scripps Research Inst | Nowe modulatory receptorów sfingozyno-1-fosforanu |
| US8580841B2 (en) | 2008-07-23 | 2013-11-12 | Arena Pharmaceuticals, Inc. | Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| CN105816453B (zh) | 2008-08-27 | 2021-03-05 | 艾尼纳制药公司 | 用于治疗自身免疫性病症和炎性病症的作为s1p1受体激动剂的经取代的三环酸衍生物 |
| SG182610A1 (en) | 2010-01-27 | 2012-08-30 | Arena Pharm Inc | Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
| CA2789480A1 (en) | 2010-03-03 | 2011-09-09 | Arena Pharmaceuticals, Inc. | Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
| KR101299512B1 (ko) * | 2011-04-19 | 2013-08-22 | 전북대학교산학협력단 | 스핑고신 1-포스페이트를 유효성분으로 함유하는 관절염 질환 치료 조성물 |
| US11007175B2 (en) | 2015-01-06 | 2021-05-18 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
| BR112017027656B1 (pt) | 2015-06-22 | 2023-12-05 | Arena Pharmaceuticals, Inc. | Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo |
| RU2615765C1 (ru) * | 2016-04-11 | 2017-04-11 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Уфимский государственный нефтяной технический университет" | Способ получения диалкилциклопент-3-ен-1,1-дикарбоксилата |
| CA3053418A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
| JP2020507610A (ja) | 2017-02-16 | 2020-03-12 | アリーナ ファーマシューティカルズ， インコーポレイテッド | 腸管外症状を伴う炎症性腸疾患の治療のための化合物および方法 |
| BR112020024762A2 (pt) | 2018-06-06 | 2021-03-23 | Arena Pharmaceuticals, Inc. | métodos de tratamento de condições relacionadas ao receptor s1p1 |
| CN119751336A (zh) | 2018-09-06 | 2025-04-04 | 艾尼纳制药公司 | 可用于治疗自身免疫性病症和炎性病症的化合物 |
| CA3264754A1 (en) * | 2022-09-21 | 2024-03-28 | Bristol Myers Squibb Co | PROCESS FOR THE PREPARATION OF TERT-BUTYL(2-AZABICYCLO[2.2.1]HEPTAN-4-YL)CARBAMATE AND ASSOCIATED COMPOUNDS |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE599916A (enExample) * | 1960-02-05 | |||
| US3325360A (en) * | 1963-11-25 | 1967-06-13 | Carter Prod Inc | Pyrimidine-di-one pharmaceutical compositions having anti-inflammatory activity |
| US4464531A (en) * | 1981-04-20 | 1984-08-07 | Sumitomo Chemical Company, Limited | 4-Carbamoylimidazolium-5-olate derivatives |
| US5482971A (en) * | 1993-10-01 | 1996-01-09 | American Cyanamid Company | Beta3 -adrenergic agents and their use in pharmaceutical compositions |
| US5480908A (en) * | 1993-12-13 | 1996-01-02 | American Cyanamid Company | β3 -adrenergic agents benzodioxole dicarboxylates and their use in pharmaceutical compositions |
| US5488064A (en) * | 1994-05-02 | 1996-01-30 | Bristol-Myers Squibb Company | Benzo 1,3 dioxole derivatives |
| WO1996001260A1 (en) * | 1994-07-01 | 1996-01-18 | Dainippon Pharmaceutical Co., Ltd. | Pyridonecarboxylic acid derivative, ester thereof, salt thereof, and intermediate for synthesis of these compounds |
| WO1997029078A1 (en) * | 1996-02-07 | 1997-08-14 | Banyu Pharmaceutical Co., Ltd. | Cyclic amic acid derivatives |
| EP0801060A1 (en) * | 1996-04-09 | 1997-10-15 | Pfizer Inc. | Heterocyclic Beta-3 Adrenergenic Agonists |
| US5914339A (en) * | 1996-05-14 | 1999-06-22 | American Home Products Corporation | Substituted 1,3-benzodioxoles |
| JPH10245369A (ja) * | 1997-03-03 | 1998-09-14 | Ajinomoto Co Inc | セリン誘導体の製造方法 |
| US6124361A (en) * | 1997-12-31 | 2000-09-26 | Pfizer Inc | Bicyclo[3.1.0]hexanes and related compounds |
| EP1082306A1 (en) * | 1998-05-26 | 2001-03-14 | Warner-Lambert Company | Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| WO2000015604A1 (fr) * | 1998-09-11 | 2000-03-23 | Kyorin Pharmaceutical Co., Ltd. | Derives de diesters maloniques et leur procede d'obtention |
| JP4316787B2 (ja) * | 2000-01-11 | 2009-08-19 | 壽製薬株式会社 | エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、 |
| GB0118238D0 (en) * | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
| AU2003216054B2 (en) * | 2002-01-18 | 2007-01-04 | Merck & Co., Inc. | Selective S1P1/Edg1 receptor agonists |
| JP4709488B2 (ja) * | 2002-01-18 | 2011-06-22 | メルク・シャープ・エンド・ドーム・コーポレイション | Ｅｄｇ受容体作動薬としてのＮ−（ベンジル）アミノアルキルカルボン酸化合物、ホスフィン酸化合物、ホスホン酸化合物およびテトラゾール類 |
| CN1708293A (zh) * | 2002-09-24 | 2005-12-14 | 诺瓦提斯公司 | 治疗脱髓鞘疾病的鞘氨醇－1－磷酸受体激动剂 |
| AU2003279915A1 (en) * | 2002-10-15 | 2004-05-04 | Merck And Co., Inc. | Process for making azetidine-3-carboxylic acid |
| EP1581509B1 (en) * | 2002-12-20 | 2011-01-19 | Merck Sharp & Dohme Corp. | 1-(amino)indanes as edg receptor agonists |
| TW200505834A (en) * | 2003-03-18 | 2005-02-16 | Sankyo Co | Sulfamide derivative and the pharmaceutical composition thereof |
-
2004
- 2004-10-22 SI SI200430828T patent/SI1650186T1/sl unknown
- 2004-10-22 DE DE602004014277T patent/DE602004014277D1/de not_active Expired - Lifetime
- 2004-10-22 AT AT04292517T patent/ATE397582T1/de active
- 2004-10-22 PT PT04292517T patent/PT1650186E/pt unknown
- 2004-10-22 DK DK04292517T patent/DK1650186T3/da active
- 2004-10-22 PL PL04292517T patent/PL1650186T3/pl unknown
- 2004-10-22 EP EP04292517A patent/EP1650186B1/en not_active Expired - Lifetime
- 2004-10-22 ES ES04292517T patent/ES2308127T3/es not_active Expired - Lifetime
-
2005
- 2005-10-18 KR KR1020077011042A patent/KR20070097418A/ko not_active Ceased
- 2005-10-18 WO PCT/IB2005/003113 patent/WO2006043149A2/en not_active Ceased
- 2005-10-18 AP AP2007004001A patent/AP2007004001A0/xx unknown
- 2005-10-18 MX MX2007004847A patent/MX2007004847A/es active IP Right Grant
- 2005-10-18 BR BRPI0516988-7A patent/BRPI0516988A/pt not_active IP Right Cessation
- 2005-10-18 EA EA200700931A patent/EA200700931A1/ru unknown
- 2005-10-18 US US11/577,792 patent/US20090264469A1/en not_active Abandoned
- 2005-10-18 AU AU2005297138A patent/AU2005297138A1/en not_active Abandoned
- 2005-10-18 CN CNA2005800405350A patent/CN101107218A/zh active Pending
- 2005-10-18 CA CA002584610A patent/CA2584610A1/en not_active Abandoned
- 2005-10-18 JP JP2007537410A patent/JP2008517897A/ja active Pending
-
2007
- 2007-04-19 IL IL182678A patent/IL182678A0/en unknown
-
2008
- 2008-09-03 HR HR20080431T patent/HRP20080431T3/xx unknown
- 2008-09-04 CY CY20081100957T patent/CY1108321T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008517897A5 (enExample) | ||
| RU2020110780A (ru) | Ингибитор fgfr и его медицинское применение | |
| RU2360912C2 (ru) | Замещенные дигидрохиназолины с противовирусными свойствами | |
| RU2012110246A (ru) | Замещенные бензоазепины в качестве модуляторов toll-подобного рецептора | |
| JP2012236838A5 (enExample) | ||
| JP2013502430A5 (enExample) | ||
| AR051248A1 (es) | Derivados de 3-arilamino piridina | |
| RU2011103741A (ru) | Композиции и способы лечения заболевания сетчатки | |
| WO2012107706A8 (en) | Phenothiazine diaminium salts and their use | |
| RU2016103139A (ru) | Новые композиции для предупреждения и/или лечения лизосомных болезней накопления | |
| RU2006107653A (ru) | Связующее вспомогательное вещество и приготовленная на его основе таблетка в форме капли | |
| RU2012144438A (ru) | Производные 1-(2-фторбифенил-4-ил)-алкилкарбоновой кислоты для лечения транстиретинового амилоидоза | |
| JP2012526728A5 (enExample) | ||
| JP2011529468A5 (enExample) | ||
| JP2012522729A5 (enExample) | ||
| ME02554B (me) | Ibat inhibitori za lečenje bolesti jetre | |
| RU2012112471A (ru) | Аминотетрагидропираны в качестве ингибиторов дипептидилпептидазы-iv для лечения или предупреждения диабета | |
| RU2008119651A (ru) | Производные дикарбоновых кислот и их применение | |
| JP2016531126A5 (enExample) | ||
| RU2016151420A (ru) | Новое терапевтическое применение производных бензилиденгуанидина для лечения протеинопатий | |
| RU2020106383A (ru) | 3,4-двузамещенные 3-циклобутен-1,2-дионы и их применение | |
| AR056892A1 (es) | Derivados de cinolin-3-carboxamida, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mediadas por la modulacion del receptor gabaa | |
| RU2006139140A (ru) | Средства и способы для лечения нарушений свертываемости | |
| RU2008119465A (ru) | Производные циклопропилуксусной кислоты и их применение | |
| RU2012129887A (ru) | Ингибиторы мк2 |